LY2422347

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY2422347, covering 2007-01-26 to 2007-01-26. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy Study of LY2422347 to Treat Insomnia [Phase 2]